A detailed history of Allianz Asset Management Gmb H transactions in Novartis Ag stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 7,800 shares of NVS stock, worth $772,824. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,800
Previous 7,800 -0.0%
Holding current value
$772,824
Previous $830,000 8.07%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$92.57 - $107.37 $722,046 - $837,486
7,800 New
7,800 $830,000
Q2 2022

Aug 12, 2022

SELL
$80.52 - $93.75 $5.94 Million - $6.92 Million
-73,785 Reduced 61.44%
46,316 $3.92 Million
Q1 2022

May 13, 2022

SELL
$80.11 - $90.62 $76,104 - $86,089
-950 Reduced 0.78%
120,101 $10.5 Million
Q4 2021

Feb 11, 2022

SELL
$79.7 - $88.13 $72,925 - $80,638
-915 Reduced 0.75%
121,051 $10.6 Million
Q3 2021

Nov 10, 2021

BUY
$81.78 - $95.14 $867,685 - $1.01 Million
10,610 Added 9.53%
121,966 $9.97 Million
Q2 2021

Aug 16, 2021

SELL
$85.24 - $94.15 $222,902 - $246,202
-2,615 Reduced 2.29%
111,356 $10.2 Million
Q1 2021

May 13, 2021

SELL
$83.5 - $98.47 $792,832 - $934,972
-9,495 Reduced 7.69%
113,971 $9.74 Million
Q4 2020

Feb 16, 2021

SELL
$78.07 - $94.43 $2.41 Million - $2.92 Million
-30,918 Reduced 20.03%
123,466 $11.7 Million
Q3 2020

Nov 13, 2020

BUY
$82.14 - $91.0 $2,382 - $2,639
29 Added 0.02%
154,384 $13.4 Million
Q2 2020

Aug 14, 2020

SELL
$80.93 - $91.1 $1.12 Million - $1.26 Million
-13,830 Reduced 8.22%
154,355 $13.5 Million
Q1 2020

May 14, 2020

BUY
$70.67 - $99.01 $598,150 - $838,020
8,464 Added 5.3%
168,185 $13.9 Million
Q4 2019

Feb 13, 2020

BUY
$84.35 - $95.37 $916,462 - $1.04 Million
10,865 Added 7.3%
159,721 $15.1 Million
Q3 2019

Nov 13, 2019

SELL
$85.54 - $94.26 $1.34 Million - $1.47 Million
-15,640 Reduced 9.51%
148,856 $12.9 Million
Q2 2019

Aug 08, 2019

BUY
$75.4 - $92.8 $353,249 - $434,768
4,685 Added 2.93%
164,496 $15 Million
Q1 2019

May 13, 2019

BUY
$75.32 - $86.15 $899,697 - $1.03 Million
11,945 Added 8.08%
159,811 $15.4 Million
Q4 2018

Feb 14, 2019

SELL
$73.66 - $82.02 $4.48 Million - $4.99 Million
-60,850 Reduced 29.15%
147,866 $12.7 Million
Q3 2018

Nov 13, 2018

BUY
$66.94 - $77.43 $11.1 Million - $12.8 Million
165,735 Added 385.6%
208,716 $18 Million
Q2 2018

Aug 13, 2018

BUY
$64.91 - $73.36 $21,874 - $24,722
337 Added 0.79%
42,981 $3.25 Million
Q1 2018

May 14, 2018

BUY
$70.39 - $84.15 $24,143 - $28,863
343 Added 0.81%
42,644 $3.45 Million
Q4 2017

Feb 13, 2018

BUY
$72.33 - $77.64 $412,281 - $442,548
5,700 Added 15.57%
42,301 $3.55 Million
Q2 2017

Aug 14, 2017

SELL
N/A
-413 Reduced 1.12%
36,601 $3.06 Million
Q1 2017

Apr 17, 2019

SELL
N/A
-2,554 Reduced 6.45%
37,014 $2.75 Million
Q4 2016

Apr 17, 2019

BUY
N/A
335 Added 0.85%
39,568 $2.88 Million
Q3 2016

Apr 17, 2019

BUY
N/A
39,233
39,233 $3.1 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $213B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Allianz Asset Management Gmb H Portfolio

Follow Allianz Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.